Though Trump took a national abortion ban off the table, they’re still pushing to restrict abortion pills via FDA and EPA regulations.

The looming expiration of Obamacare subsidies for tens of millions of Americans has more lawmakers — particularly vulnerable Republicans — sweating the political fallout and ready to compromise. But odds for a deal remain slim, and an unresolved fight over abortion could lower them to zero.

President Trump's advisers are furious with Sen. Josh Hawley (R-Mo.) for starting an anti-abortion group to spur new action on the issue, which the White House views as a loser for Republicans in next year's midterms.

Two state lawmakers are sparring over how to enshrine protections in state law for women who have miscarriages or other pregnancy complications

The Food and Drug Administration has delayed a promised review of safety data for the abortion drug mifepristone at Commissioner Marty Makary’s request to put it off until after the midterm elections,

Following a pressure campaign from anti-abortion groups, Makary and Health and Human Services Secretary Robert F. Kennedy Jr. announced in June that they would conduct a new assessment of mifepristone despite the drug’s 25-year safety record.

Maine Gov. Janet Mills, known for advancing abortion rights, receives a key endorsement for her 2026 Senate bid against incumbent Susan Collins.

Marjorie Dannenfelser called for FDA Commissioner Marty Makary to be fired for allegedly delaying a mifepristone safety review.